Idiopathic pulmonary fibrosis: Addressing the current and future therapeutic advances along with the role of Sotatercept in the management of pulmonary hypertension
- DOI
- 10.1002/iid3.1079
- Published
- 2023-11
- Container
- Immunity, Inflammation and Disease
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/iid3.1079,
title = {Idiopathic pulmonary fibrosis: Addressing the current and future therapeutic advances along with the role of Sotatercept in the management of pulmonary hypertension},
author = {Dalia D. Hadi and Mohammed Dheyaa Marsool Marsool and Ali Dheyaa Marsool Marsool and Neel Vora and Sajjad G. Al‐Badri and Nabeel H. K. Al‐Fatlawi and Ameer F. Abbas Al Wssawi and Abdullah M. T. Al‐Ibraheem and Khadija A. Hamza and Priyadarshi Prajjwal and Mohammed A. Mateen and Omniat Amir},
year = {2023},
journal = {Immunity, Inflammation and Disease},
doi = {10.1002/iid3.1079},
url = {https://doi.org/10.1002/iid3.1079}
}RIS
TY - JOUR TI - Idiopathic pulmonary fibrosis: Addressing the current and future therapeutic advances along with the role of Sotatercept in the management of pulmonary hypertension AU - Dalia D. Hadi AU - Mohammed Dheyaa Marsool Marsool AU - Ali Dheyaa Marsool Marsool AU - Neel Vora AU - Sajjad G. Al‐Badri AU - Nabeel H. K. Al‐Fatlawi AU - Ameer F. Abbas Al Wssawi AU - Abdullah M. T. Al‐Ibraheem AU - Khadija A. Hamza AU - Priyadarshi Prajjwal AU - Mohammed A. Mateen AU - Omniat Amir PY - 2023 JO - Immunity, Inflammation and Disease DO - 10.1002/iid3.1079 UR - https://doi.org/10.1002/iid3.1079 ER -
APA
Hadi, D. D., Marsool, M. D. M., Marsool, A. D. M., Vora, N., Al‐Badri, S. G., Al‐Fatlawi, N. H. K., Wssawi, A. F. A. A., Al‐Ibraheem, A. M. T., Hamza, K. A., Prajjwal, P., Mateen, M. A., & Amir, O. (2023). Idiopathic pulmonary fibrosis: Addressing the current and future therapeutic advances along with the role of Sotatercept in the management of pulmonary hypertension. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.1079
Source records
- crossref · retrieved 2026-09-25T14:56:05.572Z